Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coagulation01:09

Coagulation

9.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.4K
Coagulation01:06

Coagulation

1.1K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

11.4K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.4K
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

7.7K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.7K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

8.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

8.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic protein-reinforced DNA hydrogels with tunable biomechanics for mechanoresponsive drug release.

Materials horizons·2026
Same author

Virus-like particles based on plant viruses and bacteriophages: emerging strategies for the delivery of nucleic acid therapeutics.

Chemical science·2026
Same author

DNA-based Bi-layered effervescent ejecting microneedle (BEE MN) for glucose-responsive insulin delivery.

Materials horizons·2025
Same author

Surface-engineering RNA nanoparticles for targeted and efficient hepatocellular carcinoma drug delivery.

Biomedical materials (Bristol, England)·2025
Same author

GENRISE-induced superior extracellular vesicles for scalable therapeutic cargo delivery.

Science advances·2025
Same author

Electrochromic DNA-based bioink with rapid interfacial gelation for bioprinting applications.

Nanoscale horizons·2025

Related Experiment Video

Updated: Dec 23, 2025

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.5K

An enzymatically self-assembled DNA patch for enhanced blood coagulation.

Dajeong Kim1, Jieun Kim1, Jong Bum Lee1

  • 1Department of Chemical Engineering, University of Seoul, 163 Seoulsiripdaero, Dongdaemun-gu, Seoul, South Korea. jblee@uos.ac.kr.

Chemical Communications (Cambridge, England)
|April 29, 2020
PubMed
Summary

Researchers created a macroscopic DNA film, enzymatically generated and coated with thrombin (TB), to enhance hemostasis. This DNA patch acts as a scaffold, improving topical drug delivery and plasma coagulation for wound healing.

More Related Videos

In vitro Assembly of Semi-artificial Molecular Machine and its Use for Detection of DNA Damage
08:56

In vitro Assembly of Semi-artificial Molecular Machine and its Use for Detection of DNA Damage

Published on: January 11, 2012

11.9K
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.6K

Related Experiment Videos

Last Updated: Dec 23, 2025

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application
08:40

TAPE: A Biodegradable Hemostatic Glue Inspired by a Ubiquitous Compound in Plants for Surgical Application

Published on: June 8, 2016

14.5K
In vitro Assembly of Semi-artificial Molecular Machine and its Use for Detection of DNA Damage
08:56

In vitro Assembly of Semi-artificial Molecular Machine and its Use for Detection of DNA Damage

Published on: January 11, 2012

11.9K
Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures
08:30

Gene-therapy Inspired Polycation Coating for Protection of DNA Origami Nanostructures

Published on: January 19, 2019

9.6K

Area of Science:

  • Biomaterials science
  • Biotechnology
  • Biomedical engineering

Background:

  • DNA is explored for drug delivery applications.
  • Enzymatically generated DNA structures offer novel therapeutic potential.
  • Thrombin (TB) is crucial for hemostasis.

Purpose of the Study:

  • To develop a macroscopic DNA film for drug delivery.
  • To functionalize the DNA film with thrombin (TB) for enhanced hemostasis.
  • To investigate the efficacy of the DNA-TB construct as a topical treatment.

Main Methods:

  • Enzymatic synthesis of a macroscopic DNA film.
  • Coating the DNA film with thrombin (TB) via aptamer-protein interactions.
  • Evaluating the hemostatic performance of the DNA-TB patch in plasma.

Main Results:

  • A macroscopic DNA film was successfully generated enzymatically.
  • The DNA film effectively carried localized thrombin (TB).
  • The DNA patch significantly improved plasma hemostasis by serving as a coagulative scaffold.

Conclusions:

  • Enzymatic amplification-based DNA structures are beneficial for topical drug treatment.
  • The DNA patch demonstrates potential for accelerating hemostasis over large areas.
  • This approach offers a novel strategy for localized drug delivery and wound management.